Real world effectiveness of early ensitrelvir treatment in patients with SARS-CoV-2, a retrospective case series.

Abe S, Wannigama DL, Suzuki Y, Akaneya D, Igarashi J, Suto M, Moriya K, Ishizawa D, Okuma Y, Hongsing P, Hurst C, Saethang T, Higgins PG, Stick SM, Kicic A

Open source

DOI
10.1016/j.nmni.2024.101522
Published
2024 Dec
Container
New microbes and new infections
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.nmni.2024.101522,
  title = {Real world effectiveness of early ensitrelvir treatment in patients with SARS-CoV-2, a retrospective case series.},
  author = {Abe S and Wannigama DL and Suzuki Y and Akaneya D and Igarashi J and Suto M and Moriya K and Ishizawa D and Okuma Y and Hongsing P and Hurst C and Saethang T and Higgins PG and Stick SM and Kicic A},
  year = {2024},
  journal = {New microbes and new infections},
  doi = {10.1016/j.nmni.2024.101522},
  url = {https://doi.org/10.1016/j.nmni.2024.101522}
}

RIS

TY  - JOUR
TI  - Real world effectiveness of early ensitrelvir treatment in patients with SARS-CoV-2, a retrospective case series.
AU  - Abe S
AU  - Wannigama DL
AU  - Suzuki Y
AU  - Akaneya D
AU  - Igarashi J
AU  - Suto M
AU  - Moriya K
AU  - Ishizawa D
AU  - Okuma Y
AU  - Hongsing P
AU  - Hurst C
AU  - Saethang T
AU  - Higgins PG
AU  - Stick SM
AU  - Kicic A
PY  - 2024
JO  - New microbes and new infections
DO  - 10.1016/j.nmni.2024.101522
UR  - https://doi.org/10.1016/j.nmni.2024.101522
ER  - 

APA

S, A., DL, W., Y, S., D, A., J, I., M, S., K, M., D, I., Y, O., P, H., C, H., T, S., PG, H., SM, S., & A, K. (2024). Real world effectiveness of early ensitrelvir treatment in patients with SARS-CoV-2, a retrospective case series.. New microbes and new infections. https://doi.org/10.1016/j.nmni.2024.101522

Source records